Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marzia Nuccetelli and Sergio Bernardini.
Marzia Nuccetelli
Connection Strength
4.429
Sergio Bernardini
  1. Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virus. Int Immunopharmacol. 2021 Mar; 92:107330.
    View in: PubMed
    Score: 0.921
  2. Combined anti-SARS-CoV-2 IgA, IgG, and IgM Detection as a Better Strategy to Prevent Second Infection Spreading Waves. Immunol Invest. 2022 Feb; 51(2):233-245.
    View in: PubMed
    Score: 0.903
  3. SARS-CoV-2 infection serology: a useful tool to overcome lockdown? Cell Death Discov. 2020; 6:38.
    View in: PubMed
    Score: 0.884
  4. Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection. Int Immunopharmacol. 2021 Oct; 99:108013.
    View in: PubMed
    Score: 0.240
  5. Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study. Inflamm Res. 2021 Jun; 70(6):687-694.
    View in: PubMed
    Score: 0.236
  6. Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis. Int Immunopharmacol. 2021 Jun; 95:107512.
    View in: PubMed
    Score: 0.233
  7. Clinical validation of a second generation anti-SARS-CoV-2 IgG and IgM automated chemiluminescent immunoassay. J Med Virol. 2021 04; 93(4):2523-2528.
    View in: PubMed
    Score: 0.232
  8. Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies. Clin Rheumatol. 2021 Jul; 40(7):2939-2945.
    View in: PubMed
    Score: 0.231
  9. Bromelain Degrades Aß1-42 Monomers and Soluble Aggregates: An In Vitro Study in Cerebrospinal Fluid of Alzheimer's Disease Patients. Curr Alzheimer Res. 2018; 15(7):628-636.
    View in: PubMed
    Score: 0.187
  10. Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences. Front Pharmacol. 2021; 12:666600.
    View in: PubMed
    Score: 0.059
  11. Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study. J Am Coll Nutr. 2021 Feb 18; 1-16.
    View in: PubMed
    Score: 0.058
  12. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients. Clin Chim Acta. 2020 Oct; 509:135-138.
    View in: PubMed
    Score: 0.055
  13. Obstructive sleep apnea may induce orexinergic system and cerebral ß-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? Sleep Med. 2019 04; 56:171-176.
    View in: PubMed
    Score: 0.050
  14. Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms. J Alzheimers Dis. 2018; 66(3):993-999.
    View in: PubMed
    Score: 0.047
  15. Sleep apnoeas may represent a reversible risk factor for amyloid-ß pathology. Brain. 2017 12 01; 140(12):e75.
    View in: PubMed
    Score: 0.047
  16. Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease. J Neurol. 2017 Nov; 264(11):2215-2223.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.